Early evaluation of the Food and Drug Administration (FDA) guidance on antimicrobial use in food animals on antimicrobial resistance trends reported by the National Antimicrobial Resistance Monitoring System (2012–2019)

Deb, Liton Chandra; Jara, Manuel López; Lanzas, Cristina

doi:10.1016/j.onehlt.2023.100580

Cited by 1 publication

(1 citation statement)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A lower probability of resistance to all antimicrobials (except for tetracyclines), particularly macrolides (azithromycin and erythromycin) and quinolones (ciprofloxacin and nalidixic acid), was observed among Campylobacter isolates in the later years of the study (2019, 2020, and 2021). This finding agrees with two recent studies from the USA that showed a decrease in the probability of resistance to antimicrobials in Campylobacter isolated from chicken and turkey samples at retail [ 25 ] and slaughter [ 26 ]. Additional studies from the USA [ 27 ] and Canada [ 11 ] described a reduction of AMR in foodborne pathogens in chickens and turkeys.…”

Section: Discussionsupporting

confidence: 93%

Monitoring antimicrobial resistance in Campylobacter isolates of chickens and turkeys at the slaughter establishment level across the United States, 2013–2021

Sodagari,

Agrawal,

Sohail

et al. 2024

Epidemiol. Infect.

View full text Add to dashboard Cite

Foodborne infections with antimicrobial-resistant Campylobacter spp. remain an important public health concern. Publicly available data collected by the National Antimicrobial Resistance Monitoring System for Enteric Bacteria related to antimicrobial resistance (AMR) in Campylobacter spp. isolated from broiler chickens and turkeys at the slaughterhouse level across the United States between 2013 and 2021 were analysed. A total of 1,899 chicken-origin (1,031 Campylobacter coli (C. coli) and 868 Campylobacter jejuni (C. jejuni)) and 798 turkey-origin (673 C. coli and 123 C. jejuni) isolates were assessed. Chicken isolates exhibited high resistance to tetracycline (43.65%), moderate resistance to ciprofloxacin (19.5%), and low resistance to clindamycin (4.32%) and azithromycin (3.84%). Turkey isolates exhibited very high resistance to tetracycline (69%) and high resistance to ciprofloxacin (39%). The probability of resistance to all tested antimicrobials, except for tetracycline, significantly decreased during the latter part of the study period. Turkey-origin Campylobacter isolates had higher odds of resistance to all antimicrobials than isolates from chickens. Compared to C. jejuni isolates, C. coli isolates had higher odds of resistance to all antimicrobials, except for ciprofloxacin. The study findings emphasize the need for poultry-type-specific strategies to address differences in AMR among Campylobacter isolates.

show abstract